Treatment-Related Mortality With Bevacizumab in Cancer Patients

Source: JAMA

Follow this link for abstract

Date of publication: 02 February 2011

Publication type: Systematic review

In a nutshell:  This review incorporates a randomized control trial and to look at the risk of fatal adverse events associated with the use of Bevacizumab during chemotherapy.  The findings indicate that there is an increased likelihood of fatal adverse events for patients being treated with the drug. 

Length of publication: 7 web pages

Some important information:  Please contact your local NHS Library for the full text of the article.  Follow this link to find your local NHS Library.

Acknowledgement:National Electronic Library for Medicines (NELM)

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: